gms | German Medical Science

56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)
3èmes journées françaises de Neurochirurgie (SFNC)

Deutsche Gesellschaft für Neurochirurgie e. V.
Société Française de Neurochirurgie

07. bis 11.05.2005, Strasbourg

H2 15O PET for assessment of auditory cortex activation in stimulation by auditory brainstem implant (ABI)

H2 15O PET zur Evaluierung auditorischer Cortex-Aktivierung unter Stimulation durch das auditorische Hirnstammimplantat

Meeting Abstract

  • corresponding author C. Matthies - Neurochirurgische Klinik, Universitätsklinikum Würzburg
  • M. Lenarz - Klinik für Hals-Nasen-Ohren-Heilkunde, Medizinische Hochschule Hannover
  • K. Kniese - Neurochirurgische Klinik, Universitätsklinikum Würzburg
  • W. H. Knapp - Abteilung für Nuklearmedizin, Medizinische Hochschule Hannover
  • M. Samii - International Neuroscience Institute, Hannover
  • G. Berding - Abteilung für Nuklearmedizin, Medizinische Hochschule Hannover

Deutsche Gesellschaft für Neurochirurgie. Société Française de Neurochirurgie. 56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), 3èmes journées françaises de Neurochirurgie (SFNC). Strasbourg, 07.-11.05.2005. Düsseldorf, Köln: German Medical Science; 2005. Doc11.05.-08.03

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 4. Mai 2005

© 2005 Matthies et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.




In patients with bilateral deafness due to vestibular schwannomas (neurofibromatosis type 2, NF-2), auditory brainstem implants (ABI) are the only possibility to restore some perception of sound. The aim of the present study was to evaluate, if (1) acoustic stimulation of the ABI results in an activation of the auditory cortex and (2) whether this activation correlates to the clinical function.


Seven patients (aged 31±12 years) underwent PET activation studies performed using dedicated full-ring scanners (Siemens, Erlangen, Germany) 8 months (2-37) after unilateral ABI implantation. In each patient dynamic PET scans were acquired after bolus injection of 1.85 GBq H2 15O – twice during silence and twice during stimulation via headphones with a standardised laboratory speech test. Reconstructed PET frames acquired up to 90-sec p.i. were added and spatially normalised to the first scan obtained during silence. Scans of the same condition were added and a subtraction image (activation – silence) was calculated. If an activation in the auditory cortex could be delineated, the percent of maximum increase in count-density was obtained from ROI-data. The quality of auditory function at the time of the PET investigation was assigned to 4 classes based on consonant recognition and speech tracking test: 1 = very good, 2 = good, 3 = fair and 4 = moderate.


In patients that achieved very good or good auditory function (n=3) activity in the auditory cortex increased 20.7% ipsi- and 22.7% contralateral to the ABI. Two patients with auditory function between fair and good showed only ipsilateral activation of the auditory cortex (12.4%). In one patient with fair and another with moderate auditory function no activation was seen at all (0%). A significant negative correlation was observed between measured activation in the PET study and class of auditory function (r=-0.9, p=0.0042).


The present data suggest that above a particular limit, parallel to an increase in quality of auditory function achieved with an ABI, H2 15O PET can demonstrate an increase of auditory cortex activation. Therefore, this method is the first tool to measure auditory pathway activation objectively. Hereby, it might be a helpful adjunct to optimise programming of the ABI speech processor.